![]() Carmot Therapeutics Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer. | ||||
Founding Date | Founding Date 2004 | Founding Date 2008 | Founding Date 2017 | Founding Date 2014 |
Type | Type Subsidiary | Type Subsidiary | Type Private | Type Private |
Tags | ||||
Locations | Locations Wilmington, US HQ | Locations Berkeley, US HQ | Locations Malmö, SE HQ | Locations Baltimore, US HQ Lowell, US |
Employees | Employees 3 | Employees 109% decrease | Employees 910% decrease | Employees 9 |
Funding | ||||
Total funding raised | Total funding raised $ 4.6m | Total funding raised $ 74.8m | Total funding raised N/A | Total funding raised $ 21m |

Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer.
View company
Abarceo Pharma is a company that develops therapeutics for type-2 diabetes.
View company
glyscend is a company that develops a method of treating metabolic diseases.
View company